Utility of Testing Fibroblast Growth Factor 23 in Patients with Chronic Kidney Disease: A Single Center Experience

Introduction: Phosphate homeostasis disturbances, as well as higher circulating levels of fibroblast growth factor 23 (FGF-23), are an early consequence of CKD that can lead to a variety of bone disorders. For patients with various bone illnesses, treatment options are meant to keep calcium, phosphate, parathyroid hormone (PTH), and vitamin D levels within prescribed ranges.…
Read more


February 24, 2022 0